Clinical Trial

Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 2, 2022 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-10-20; most recent amendment 2022-11-01.
Status change: Not Yet Recruiting → Recruiting 2018-05-08
Trial Details
NCT Number NCT03321201
Lead Sponsor University of Split, School of Medicine
Collaborators: University Hospital of Split
Conditions Pterygium of Conjunctiva and Cornea
Enrollment 164 participants
Start Date 2018-05-08
Primary Completion 2025-05-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-11-02